ArticleHealth and quality of life outcomes2017

Glatiramer acetate treatment persistence - but not adherence - in multiple sclerosis patients is predicted by health-related quality of life and self-efficacy: a prospective web-based patient-centred study (CAIR study).

Peter Joseph Jongen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.